# Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis

> **NCT03334006** · PHASE2 · RECRUITING · sponsor: **RWTH Aachen University** · enrollment: 200 (estimated)

## Conditions studied

- Peritonitis
- Sepsis
- Septic Shock

## Interventions

- **DRUG:** Pentaglobin®/Standard of Care

## Key facts

- **NCT ID:** NCT03334006
- **Lead sponsor:** RWTH Aachen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-11-20
- **Primary completion:** 2027-09
- **Final completion:** 2028-03
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-09-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03334006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03334006, "Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03334006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*